HD15 for advanced stage Hodgkin's disease: Quality assurance protocol for reduction of toxicity and the prognostic relevance of fluorodeoxyglucose-positron-emission tomography (FDG-PET) in the first-line treatment of advanced stage Hodgkin's disease

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2003
This article has no abstract
Epistemonikos ID: 952fc5bfeabde491fc88071f75830de7eb535e43
First added on: Jan 17, 2025